Total Payments
$13,306
2024 Payments
$84.73
Companies
57
Transactions
813
Medicare Patients
2,968
Medicare Billing
$337,330
Payment Breakdown by Category
Food & Beverage$12,471 (93.7%)
Education$482.84 (3.6%)
Other$351.80 (2.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,471 | 786 | 93.7% |
| Education | $482.84 | 7 | 3.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $351.80 | 20 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $1,641 | 91 | $0 (2023) |
| GENZYME CORPORATION | $1,136 | 56 | $0 (2023) |
| UCB, Inc. | $779.81 | 45 | $0 (2023) |
| ACADIA Pharmaceuticals Inc | $760.82 | 46 | $0 (2023) |
| ABBVIE INC. | $660.32 | 36 | $0 (2024) |
| Allergan, Inc. | $608.06 | 51 | $0 (2022) |
| Avanir Pharmaceuticals, Inc. | $513.60 | 34 | $0 (2022) |
| EMD Serono, Inc. | $480.87 | 33 | $0 (2023) |
| Amgen Inc. | $451.47 | 26 | $0 (2023) |
| Acorda Therapeutics, Inc | $446.75 | 26 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $84.73 | 2 | ABBVIE INC. ($70.00) |
| 2023 | $1,307 | 73 | PFIZER INC. ($162.22) |
| 2022 | $2,479 | 154 | Biohaven Pharmaceutical Holding Company Ltd. ($314.32) |
| 2021 | $2,667 | 166 | Teva Pharmaceuticals USA, Inc. ($325.91) |
| 2020 | $1,323 | 92 | Allergan, Inc. ($191.72) |
| 2019 | $1,855 | 111 | GENZYME CORPORATION ($270.99) |
| 2018 | $1,512 | 90 | Teva Pharmaceuticals USA, Inc. ($252.99) |
| 2017 | $2,078 | 125 | GENZYME CORPORATION ($355.34) |
All Payment Transactions
813 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $70.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/02/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 07/31/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: NEUROLOGY | ||||||
| 07/28/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Central Nervous System | ||||||
| 07/27/2023 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $9.25 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/21/2023 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $22.80 | General |
| 07/20/2023 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Neurology | ||||||
| 07/18/2023 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/13/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: PAIN | ||||||
| 07/12/2023 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/11/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $14.69 | General |
| 07/10/2023 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Immunology | ||||||
| 07/08/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Rare Disease | ||||||
| 06/28/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: NEUROLOGY | ||||||
| 06/28/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $8.52 | General |
| Category: VACCINES | ||||||
| 06/27/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Central Nervous System | ||||||
| 06/23/2023 | Horizon Therapeutics plc | UPLIZNA (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: UPLIZNA | ||||||
| 06/22/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: VACCINES | ||||||
| 06/21/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 06/19/2023 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug), KESIMPTA | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: Neurology | ||||||
| 06/14/2023 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Parkinson's Disease | ||||||
| 06/07/2023 | Biogen, Inc. | TYSABRI (Biological) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Neurology | ||||||
| 06/02/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.90 | General |
| Category: Neuroscience | ||||||
| 06/01/2023 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA | ||||||
| 06/01/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $9.21 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 758 | 6,808 | $340,546 | $104,759 |
| 2022 | 8 | 711 | 4,373 | $274,991 | $93,194 |
| 2021 | 11 | 733 | 905 | $205,732 | $81,000 |
| 2020 | 9 | 766 | 900 | $170,552 | $58,376 |
Total Patients
2,968
Total Services
12,986
Medicare Billing
$337,330
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 351 | 455 | $112,385 | $34,293 | 30.5% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 16 | 5,885 | $88,275 | $29,070 | 32.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 131 | 149 | $54,832 | $16,990 | 31.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 60 | 60 | $27,840 | $7,637 | 27.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 60 | 60 | $20,520 | $6,457 | 31.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 30 | 50 | $9,650 | $2,879 | 29.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 35 | $5,915 | $1,830 | 30.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 19 | $6,042 | $1,754 | 29.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 28 | 52 | $5,980 | $1,606 | 26.9% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 17 | 17 | $6,715 | $1,232 | 18.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 26 | $2,392 | $1,012 | 42.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 367 | 484 | $107,704 | $36,495 | 33.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 140 | 165 | $53,860 | $19,041 | 35.4% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 11 | 3,500 | $51,400 | $17,111 | 33.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 54 | 54 | $23,058 | $7,594 | 32.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 66 | 66 | $20,514 | $6,997 | 34.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 28 | 57 | $9,278 | $2,933 | 31.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 33 | $4,697 | $1,797 | 38.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 14 | 14 | $4,480 | $1,227 | 27.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 337 | 437 | $87,400 | $34,433 | 39.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 155 | 185 | $49,950 | $20,970 | 42.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 76 | 76 | $22,268 | $8,585 | 38.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 48 | 48 | $18,720 | $7,415 | 39.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 20 | 36 | $5,400 | $1,965 | 36.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 14 | 25 | $5,375 | $1,901 | 35.4% |
About Dr. Adele Thiel, M.D
Dr. Adele Thiel, M.D is a Neurology healthcare provider based in Flowood, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992810691.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adele Thiel, M.D has received a total of $13,306 in payments from pharmaceutical and medical device companies, with $84.73 received in 2024. These payments were reported across 813 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($12,471).
As a Medicare-enrolled provider, Thiel has provided services to 2,968 Medicare beneficiaries, totaling 12,986 services with total Medicare billing of $337,330. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Specialist
- Location Flowood, MS
- Active Since 08/20/2006
- Last Updated 10/15/2018
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1992810691
Products in Payments
- AUBAGIO (Drug) $912.53
- NUPLAZID (Drug) $760.82
- Briviact (Drug) $648.72
- NURTEC ODT (Drug) $642.16
- UBRELVY (Drug) $435.68
- Aimovig (Biological) $388.45
- Fycompa (Drug) $387.78
- NUEDEXTA (Drug) $365.00
- OCREVUS (Biological) $363.58
- AJOVY (Biological) $331.42
- INBRIJA (Drug) $327.85
- COPAXONE (Drug) $321.28
- BOTOX (Biological) $319.55
- NOURIANZ (Drug) $287.99
- AUSTEDO (Drug) $253.50
- AJOVY (Drug) $238.76
- Nuedexta (Drug) $228.01
- LEMTRADA (Drug) $222.58
- QULIPTA (Drug) $206.87
- TECFIDERA (Drug) $190.84
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.